COMMUNIQUÉS West-GlobeNewswire

Yield10 Bioscience Exercises Option with University of Missouri to Obtain Exclusive Worldwide License to Advanced Technologies for Oilseed Crops
22/05/2018
WOBURN, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today [...]
Zosano Appoints Steven A. Elms to Board of Directors
22/05/2018
FREMONT, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]
Progenics Announces JAMA Oncology Publication Highlighting Company’s Imaging Analysis Platform
22/05/2018
Data Support Prognostic Utility of aBSI as an Imaging Biomarker for Survival in Patients with Castration-Resistant Prostate Cancer NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX [...]
Oxford Immunotec Announces Launch of the Accutix™ Brand
22/05/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced the launch of the Accutix brand for [...]
BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
22/05/2018
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) today announced it has closed its previously announced $50 million registered direct offering of newly designated [...]
Novo Nordisk A/S - Share repurchase programme
22/05/2018
Bagsværd, Denmark, 22 May 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]
Kane Biotech Appoints Pharmaceutical Executive Rashieda Gluck to Board of Directors
22/05/2018
WINNIPEG, Manitoba, May 22, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce it has appointed Rashieda (Rivka) Gluck to the Corporation [...]
Delcath Sponsors Looking For A Cure Ocular Melanoma Charity Event
22/05/2018
NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, is proud to sponsor A Cure In Sight [...]
Share buy-back week 20/2018
22/05/2018
Announcement 22 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]
FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes
22/05/2018
BRIDGEWATER, N.J. and THE WOODLANDS, Texas, May 22, 2018 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) has accepted Sanofi’s regulatory filing for Zynquista (sotagliflozin). The investigational oral [...]
Cognition Therapeutics Receives $6.6M in NIA Grants for Two Studies of Elayta™ to Expand Understanding of Synaptoprotective Mechanism of Action
22/05/2018
PITTSBURGH, May 22, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]
Innovate Biopharmaceuticals Scheduled to Present at BIO 2018 Convention in Boston on Tuesday, June 5, 2018, at 4:45PM
22/05/2018
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT ), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory [...]
Emerald Health Therapeutics to Present at Upcoming Investor Conferences
22/05/2018
Presentation will be webcasted and archived VICTORIA, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (Emerald) today announced that members of its executive [...]
MRI Interventions to Present at the LD Micro Invitational Conference on June 5
22/05/2018
IRVINE, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that Chief Executive Officer Joe Burnett will present at the 8th annual LD Micro Invitational on Tuesday, June 5 at [...]
Chembio Diagnostics and Massachusetts General Hospital Enter Memorandum Of Understanding to Develop Point-of-Care Fever Diagnostic Test
22/05/2018
MEDFORD, N.Y., May 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today announced that it has entered a non-binding [...]
Progressive Care Purchases TCGRx Pouch Packaging System to Add to Expanding Robot Pharmacy Machinery Fleet
22/05/2018
MIAMI, May 22, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that the company has purchased a new TCGRx Automated Pouch Packaging [...]
The Integrated Healthcare Association (IHA) Selects Gaine Healthcare and Availity to Support the Launch of the California Statewide Provider Directory Utility
22/05/2018
Selection of leading technology partners and participation of three large California network plans positions IHA well for success and scale OAKLAND, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- The Integrated Healthcare [...]
XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis
22/05/2018
First Patient Begins Therapy with MABp1 for Treatment of Atopic Dermatitis AUSTIN, Texas, May 22, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today that the first patient has been enrolled in its [...]
Incysus Moves Its Corporate Domicile to Delaware
22/05/2018
NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, announced that effective May [...]

Pages